Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6GMX

pVHL:EloB:EloC in complex with 6-chlorothiochroman-4-one

6GMX の概要
エントリーDOI10.2210/pdb6gmx/pdb
分子名称Elongin-B, Elongin-C, von Hippel-Lindau disease tumor suppressor, ... (9 entities in total)
機能のキーワードe3 ubiquitin ligase, tumor supressor, protac, fragment-based drug discovery, oncoprotein
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数12
化学式量合計167704.85
構造登録者
Van Molle, I.,Lucas, X.,Ciulli, A. (登録日: 2018-05-28, 公開日: 2018-08-08, 最終更新日: 2024-11-20)
主引用文献Lucas, X.,Van Molle, I.,Ciulli, A.
Surface Probing by Fragment-Based Screening and Computational Methods Identifies Ligandable Pockets on the von Hippel-Lindau (VHL) E3 Ubiquitin Ligase.
J. Med. Chem., 61:7387-7393, 2018
Cited by
PubMed Abstract: Beyond the targeting of E3 ubiquitin ligases to inhibit protein homeostasis, E3 ligase binders can be repurposed as targeted protein degraders (PROTACs or molecular glues). We sought to identify new binders of the VHL E3 ligase by biophysical fragment-based screening followed by X-ray crystallographic soaking. We identified fragments binding at the ElonginC:Cullin2 interface and a new cryptic pocket in VHL, along with other potential ligandable sites predicted computationally and found to bind solvent molecules in crystal structures. The elucidated interactions provide starting points for future ligand development.
PubMed: 30040896
DOI: 10.1021/acs.jmedchem.8b00842
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.533 Å)
構造検証レポート
Validation report summary of 6gmx
検証レポート(詳細版)ダウンロードをダウンロード

231029

件を2025-02-05に公開中

PDB statisticsPDBj update infoContact PDBjnumon